Skip to content

efficacy of repetitive transcranial magnetic stimulation (rTMS)in chronic migraine with vestibular symptoms

To study the Efficacy of repetitive transcranial magnetic stimulation (rTMS)in chronic migraine with vestibular symptoms, An open labelled randomized sham control study. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060797
Enrollment
62
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G438- Other migraine

Interventions

Intervention1: repetitive transcranial magnetic stimulation (rTMS): Each rTMS session will last 412.4 seconds and deliver 600 pulses.The impulses will be delivered in 10 trains, each containing 60 pul

Sponsors

AIIMS Bhunaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients fulfilling the diagnostic criteria of chronic migraine according to ICHD-3criteria , that is headaches on 15 days or more days per month in a patient with prior migraine history , with at least 8 days per month being migraine for at least 3 months . b)Patients with chronic migraine with vestibular symptoms . c)Adults of > 18 years of age.

Exclusion criteria

Exclusion criteria: a)Patients with prior history of hearing loss ,non migranous vestibular symptoms , hearing aids , implants . b)Patients with pregnancy,CLD,CKD,malignancy,severe hypertension, pacemaker or metallic implants, and history of seizures or structural brain lesions , advanced heart failure have been excluded .

Design outcomes

Primary

MeasureTime frame
1.The primary outcome measures were defined at 1 month as follows: a)Reduction in headache frequency by 50% b)Improvement in severity on Visual Analogue Scale (VAS) (0-100) by 50 % c)Functional disability d)Adverse events e)Reduction of DHI score 50%Timepoint: The primary outcome measures were defined at 1 month

Secondary

MeasureTime frame
Secondary outcome will be 1. To study the assessment of VEMP a)Mean peak latency N10 , P15 and amplitude N10-P15 oVEMP. b)Mean peak latency of P13, N23 and amplitude of P13- N23 of cVEMP . c)Inter aural difference with Asymmetric ratio( AR) of oVEMP, cVEMP.Timepoint: The outcome parameters were noted after each rTMS session; thereafter at the 4th week. The patients visited for follow-up at 1 month

Countries

India

Contacts

Public ContactDr Karnati Uday Kumar

aiims bhubaneswar

bhoisanjeev@gmail.com9919787978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026